Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double‐blind, multicentre, randomized study

Abstract

In patients with poorly controlled type 2 diabetes, addition of pioglitazone to insulin significantly improved glycaemic control, had a positive effect on important components of the lipid profile in a dose-dependent manner and was generally well tolerated.